Cargando…
Interferon-α2a treatment for refractory Behçet's disease
We report a young male patient with Behçet's disease who suffered from sight-threatening recurrences under treatment with azathioprine, cyclosporine, and prednisolone. His uveitis responded well to antitumor necrosis factor (TNF)-alpha (adalimumab) for 5 months subsequently. Severe uveitis recu...
Autores principales: | Lai, Yung Jen, Chan, Wei-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169326/ https://www.ncbi.nlm.nih.gov/pubmed/30294531 http://dx.doi.org/10.4103/tjo.tjo_99_17 |
Ejemplares similares
-
Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease
por: Park, Ji-Youn, et al.
Publicado: (2015) -
Effectiveness and safety of interferon α2a as an add-on treatment for
refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019) -
Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
por: Lee, Ji Hwan, et al.
Publicado: (2018) -
Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
por: Guney, Esra, et al.
Publicado: (2012) -
Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease
por: Kaji, Mariko, et al.
Publicado: (2015)